Celonic

Basel, Switzerland Founded: 1998 • Age: 28 yrs
Provides contract development and manufacturing services for biologics to biotech companies.

About Celonic

Celonic is a Healthcare company based in Basel (Switzerland) founded in 1998. It provides contract development and manufacturing services for biologics to biotech companies. It operates on a B2B and Service-based model. Celonic has completed 1 acquisition, including Glycotope. Celonic offers products and services including Preclinical Services, Clinical Supply, and Late Phase Supply. Its focus areas include Biotechnology, Drug Manufacturing, Process Development and Biologics. Its legal entity is Celonic AG.

Company details

Celonic Group operates as a biologics Contract Development Manufacturing Organization, offering end-to-end solutions for drug substance development and manufacturing. They focus on monoclonal antibodies and complex molecules, from cell line development to commercial production. Based in Switzerland and Germany, Celonic serves small to large biotech and biosimilar companies, using next-generation technologies to lower costs and improve drug accessibility. Their services include preclinical, clinical, and late-phase supply through collaborative partnerships.

  • Headquarters Basel, Switzerland
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website celonic.com
  • Social LinkedIn
  • Legal Name Celonic Ag
Key Metrics

Products & Services of Celonic

Celonic offers a comprehensive portfolio of products and services, including Preclinical Services, Clinical Supply, and Late Phase Supply.

Preclinical Services
Development Services

Offers development for early-stage biologics testing and optimization.

Clinical Supply
Manufacturing Services

Provides manufacturing for clinical trial drug supplies.

Late Phase Supply
Commercial Services

Handles production for market-ready biologics and supply chains.

People of Celonic

6 people are tracked at Celonic (5 in leadership, 1 in team).

NameRoleGroup
Stéphane Denépoux
Director Of Business DevelopmentLeadership
Samanta Cimitan
Chief Executive OfficerLeadership
Alex Villiger
CFOLeadership
Elisa Cristina Witt
Marketing, Insights And Communications Manager, Member Of The CEO OfficeLeadership
Silvina Valle
Head Of ControllingLeadership
Biserka Misev
Manager AccountingTeam
Premium access

Complete people profiles for Celonic

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Celonic

Celonic has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Glycotope.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Developer of Glyco-optimized antibodies and provider of contract research and manufacturing services.
glycotope.comBerlin, Germany2001Nov 2017β€’β€’β€’β€’
Premium access

Complete acquisition details for Celonic

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Celonic

2 dated milestones of Celonic across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Celonic is founded.
  2. Acquisition Acquires Glycotope.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Celonic

Premium access

Complete news archive for Celonic

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Celonic

Celonic was founded in 1998.

Celonic is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.

Celonic Group operates as a biologics Contract Development Manufacturing Organization, offering end-to-end solutions for drug substance development and manufacturing. They focus on monoclonal antibodies and complex molecules, from cell line development to commercial production. Based in Switzerland and Germany, Celonic serves small to large biotech and biosimilar companies, using next-generation technologies to lower costs and improve drug accessibility. Their services include preclinical, clinical, and late-phase supply through collaborative partnerships.

Celonic offers Preclinical Services, Clinical Supply, and Late Phase Supply.

Celonic has made 1 acquisition, including Glycotope.

Celonic operates through Celonic Ag.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available